Table 2 Self-reported adverse events throughout 6 months of therapy deemed “probably” or “definitely” related to FMT
From: Faecal microbiota transplant in Parkinson’s disease: pilot study to establish safety & tolerability
Adverse event | Number of Patients (%) |
|---|---|
Nausea | 3 (25%) |
Bloating | 5 (42%) |
Abdominal pain/cramping | 4 (33%) |
Diarrhoea | 3 (25%) |
Constipation | 7 (58%) |
Increased flatulence | 6 (50%) |
